http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#Head http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#assertion http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#provenance http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#pubinfo http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#assertion http://purl.obolibrary.org/obo/DOID_9700 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9700 http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB06771 http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association http://www.w3.org/2000/01/rdf-schema#label besivance tm besifloxacin ophthalmic suspension 6 is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria cdc coryneform group g corynebacterium pseudodiphtheriticum corynebacterium striatum haemophilus influenzae moraxella lacunata staphylococcus aureus staphylococcus epidermidis staphylococcus hominis staphylococcus lugdunensis streptococcus mitis group streptococcus oralis streptococcus pneumoniae streptococcus salivarius efficacy for this organism was studied in fewer than 1 infections besivance tm besifloxacin ophthalmic suspension 6 is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria cdc coryneform group g corynebacterium pseudodiphtheriticum corynebacterium striatum haemophilus influenzae moraxella lacunata staphylococcus aureus staphylococcus epidermidis staphylococcus hominis staphylococcus lugdunensis streptococcus mitis group streptococcus oralis streptococcus pneumoniae streptococcus salivarius efficacy for this organism was studied in fewer than 1 infections 1 http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB06771 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#provenance http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#pubinfo http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#sig http://purl.org/nanopub/x/hasSignature Q3AOSvy181nt9/E5LigGyVhIhPnHlCOad+AqWE/WGqLtMvsw0zcofcx67Vy051KDc4qII1XXxO7O+OEeqfoVhHQ+mxNhnUZDZGFX9Q3K2on9I0Vv+xIyYadJ/gXbUpWn1fqSwIRiOBF913pJTRmWEe1P4QiNr1cuCab++Jtwc8c= http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc http://purl.org/dc/terms/created 2021-06-12T15:52:50.916+02:00 http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAdjqAaVwvHmvyIjS5OAeks03mxUYXUfiv81Tyn3wgIbc https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs